ART and tuberculosis: The final nail in nevirapine's coffin?
Division of Clinical Pharmacology, Department of Medicine, University of Cape Town, Cape Town, South Africa. Electronic address: .The Lancet Infectious Diseases (Impact Factor: 22.43). 02/2013; 13(4). DOI: 10.1016/S1473-3099(13)70049-5
Data provided are for informational purposes only. Although carefully collected, accuracy cannot be guaranteed. The impact factor represents a rough estimation of the journal's impact factor and does not reflect the actual current impact factor. Publisher conditions are provided by RoMEO. Differing provisions from the publisher's actual policy or licence agreement may be applicable.